Vertex Pharmaceuticals Inc
(WBO:VRTX)
€
410.1
+10.05 (+2.51%)
Market Cap: 104.05 Bil
Enterprise Value: 99.44 Bil
PE Ratio: 27.78
PB Ratio: 6.15
GF Score: 90/100 Vertex Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript
Jun 10, 2026 / 03:20PM GMT
Release Date Price:
€381.1
(-0.79%)
Salveen Richter
Goldman Sachs International - Analyst
Good morning, everyone. Thank you so much for joining us. It's my pleasure to introduce Vertex Pharmaceuticals. And with us, we have Reshma Kewalramani, who's President and CEO of the company. Reshma, thank you for being here.
Reshma Kewalramani
Vertex Pharmaceuticals Inc - President, Chief Executive Officer, Director
You bet.
Questions & Answers
Salveen Richter
Goldman Sachs International - Analyst
Maybe just start here a high-level overview on the company. Help us understand where Vertex stands today in terms of your core cystic fibrosis and emerging pain and kidney autoimmune franchises, the key pipeline priorities and the outlook and strategy for the company as we head into the end of the decade.
Reshma Kewalramani
Vertex Pharmaceuticals Inc - President, Chief Executive Officer, Director
Sure thing. Sounds good. First of all, it's very nice to be here with you, Salveen. I know we're the last fireside
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot